LivaNova Q1 revenue up 9.7% to $263M, EPS $0.14, raises 2023 guidance; names interim CEO

LivaNova PLC

2023-Q1 EPS reported $0.14 revenue$263,418,000

Revenue $263.4M, +9.7% reported (+12.7% constant currency) vs. prior year.
GAAP diluted EPS $0.14; adjusted diluted EPS $0.43.
Received FDA 510(k) clearance for Essenz heart-lung machine.
Randomized 500th unipolar depression patient in RECOVER study.
Bill Kozy appointed interim CEO after Damien McDonald's resignation; full-year 2023 guidance raised.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

LivaNova PLC reported the quarter ended March 31, 2023 results: revenue $263.4 million, net income $0.14 per share, EPS $0.14. Guidance raised.

Period: the quarter ended March 31, 2023
Revenue: $263.4 million
Net income: $0.14 per share
EPS: $0.14
Guidance: raised
Result: reported results

Exact text from the filing

innovation company, today reported results for the quarter ended March 31, 2023 and raised full-year 2023 guidance. Financial Summary and Highlights 1 • First-quarter revenue of $263.4 million increased 9.7 percent on a reported basis and increased 12.7 percent on a constant-currency basis, as compared to the prior-year period • First-quarter U.S. GAAP diluted earnings

View on SEC.gov

Browse all earnings releases →

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-23-000043

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.